Polycystic ovary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. PCOS was diagnosed according to the Rotterdam criteria in 2003 2. No hormone drugs were taken in the 3 months prior to inclusion 3. IVF/ICSI assisted pregnancy with a flexible antagonist regimen 4. Sign relevant informed consent
Exclusion criteria
Exclusion criteria: 1. Uterine lesions (such as adenomyosis, uterine adhesions, uterine malformations) 2. Other diseases that can cause hyperandrogenemia or abnormal ovulation (such as hyperprolactinemia, thyroid diseases, adrenal tumors, etc.) 3. History of surgery on either ovary 4. Patients with kidney, liver, heart disease, and hematopoietic dysfunction 5. Either spouse has chromosomal abnormalities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| D3 high-quality embryos rate;Gn days; | — |
Secondary
| Measure | Time frame |
|---|---|
| fertilization rate;total fertilization rate;normal fertilization rate;high quality blastocyst rate;blastocyst transformation rate;freezable blastula rate;embryo implantation rate;biochemical pregnancy rate;clinical pregnancy rate;miscarrige rate;live birth rate;cycle cancellation rate;multiple birth rate;age;protocol fertilization;duration of infertility;body mass index;basal FSH;basal E2;basal P;basal LH;basal T;AFC;infertility factor;total Gn amount;total GnRH-ant amount ;GnRH-ant amount after initiating;LH on day of initiating;FSH on day of initiating;P on day of initiating ;E2 on day of initiating day;E2 on day of antagonist addition day;LH on day of antagonist addition;P on day of antagonist day ;endometrial thickness on day of hCG trigger;E2 on day of hCG trigger;LH on day of hCG trigger;P on day of hCG trigger;number of oocytes retrieved;MII oocyte rate;2PN rate;cumulative pregnancy rate;cumulative live birth rate; | — |
Countries
China
Contacts
The People's Hospital of Guangxi Zhuang Autonomous Region